Clinical Trial Update: Evaluation of ClearLLab LS Screening Panel

View source ↗

Summary

Beckman Coulter completed a clinical trial evaluating the ClearLLab LS Screening Panel for hematologic malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Hematologic Malignancies
• Hematologic Neoplasms

Snippet

Sponsor: Beckman Coulter, Inc. | Conditions: Hematologic Malignancy, Hematologic Neoplasms | Status: COMPLETED